🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a prospective, open-label, multicenter, randomized controlled...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-06-15
Trial ID
NCT07005557
Treatments Being Tested
This study is a multicenter, prospective, randomized, open-label clinical s...
Status
Recruiting
Location
Fujian Cancer Hosptial
Start Date
2026-01-21
Trial ID
NCT07581834
Evaluate the efficacy and safety of Dalpiciclib combined with aromatase inh...
Status
Unknown
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2022-10-01
Trial ID
NCT05640778
Treatments Being Tested
This study is a multi-center, randomized, prospective phase II clinical tri...
Status
Recruiting
Location
The Fourth Hospital of Hebei Medical University
Start Date
2023-09-30
Trial ID
NCT06107673
This is a prospective, single-arm, multicenter Phase II study of patients w...
Status
Recruiting
Location
Tongji Hospital Affiliated of Tongji Medical College Huazhong University of Science and Technology
Start Date
2024-01-11
Trial ID
NCT06149130
Treatments Being Tested
This is a phase II, single-arm, prospective exploratory study to evaluate t...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06
Trial ID
NCT07618923
Treatments Being Tested
This is a randomized, controlled, open-label, phase III study to explore th...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2024-02-01
Trial ID
NCT06447623
Treatments Being Tested
In recent years, the successful application of cyclin-dependent kinase 4/6 ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-01
Trial ID
NCT07706933
Treatments Being Tested
This is a randomized, controlled, open-label, phase II study to explore the...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2023-07-26
Trial ID
NCT05949541
This is a single-center Ib / II study of triple targeted drug combination (...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2019-05-12
Trial ID
NCT03772353
Treatments Being Tested